The companies distribute their automated insulin delivery offering through Mediq, a leading European diabetes provider. Mediq serves as the exclusive distributor for the DBLG1 system and the Dana-i pump by Sooil.
Paris-based Diabeloop develops therapeutic artificial intelligence (AI) applied to insulin delivery. The company began its cooperation with Sooil in February 2020. They announced a collaboration on automated insulin delivery in 2022.
Dana-i, the latest version of the Dana pump, now pairs with the DBLG1 self-learning algorithm for insulin delivery. According to a news release, Mediq plans to support a German rollout in an initial phase for patients already using a Dexcom G6 CGM.
Next steps include launching DBLG2, the version available on smartphones, paired with the latest-generation Dexcom G7.
“We are committed to offering more choices to people with diabetes,” said Cécile Ferracci, chief commercial officer of Diabeloop. “Thanks to this partnership with Sooil — an outcome of our interoperability strategy — we are proud to now offer three options to patients in Germany: DBLG1 with Accu-Chek Insight (Roche), DBLG1 with Kaleido (Vicentra), and DBLG1 with Dana-i. All three systems are integrated with the Dexcom G6 continuous glucose monitor.”
